Jump to content

Axon Neuroscience announces positive results from Phase II trial for a cure to Alzheimer’s Disease


Recommended Posts

Today, Axon Neuroscience has announced the results of the Phase II trial for AADvac1, its first-in-class vaccine aimed at slowing down the progression of Alzheimer’s Disease.

The Phase II ADAMANT trial was designed as a randomized, double-blinded, placebo-controlled trial in mild Alzheimer’s Disease. The primary objective was safety, with secondary objectives to evaluate immunogenicity, efficacy on clinical outcomes and key biomarkers.

Axon studied AADvac1 on 196 patients in eight European countries over 24 months, in order to prove the concept of disease modifying effect of the vaccine and to inform the design of future confirmatory studies.

Dr James Pickett, Head of Research at Alzheimer’s Society, said:

'We have seen the failure of many amyloid targeting drugs for Alzheimer’s over the past few years, so all eyes are on tau to see if targeting it could help stave off the condition.

More here: https://www.alzheimers.org.uk/news/2019-09-09/axon-neuroscience-announces-positive-results-phase-ii-trial-cure-alzheimers-disease


http://www.rvroadie.com Email on the bottom of my website page.
Retired AF 1971-1998

When you see a worthy man, endeavor to emulate him. When you see an unworthy man, look inside yourself. - Confucius


“Those who can make you believe absurdities, can make you commit atrocities.” ... Voltaire

Link to comment
Share on other sites

  • 1 year later...

I cared for my mother as she went through dementia. Never did have full blown Alzheimer's but still bad and eventually destroyed her memory. She lived with it for 7 years after diagnosis, 5 of those in long term care. We suspect she had early stage for several years before diagnosis. 


'The results suggest the mechanics of the drug are working, but we shouldn’t get too excited as we’ve seen this before in early trials of drugs, that have then turned out to fail.  We now know that the drug is safe, can activate the immune system and may have positive effects in this small group of people. What we need now is large-scale trials which will have the power to find out whether this drug could be capable of slowing down Alzheimer’s. Research will beat dementia, but we need funding to make it happen.'


Good travelin !...............Kirk

Full-time 11+ years...... Now seasonal travelers.
Kirk & Pam's Great RV Adventure



Link to comment
Share on other sites

  • 2 weeks later...

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

RVers Online University


RV Destinations

Find out more or sign up for Escapees RV'ers Bootcamp.

Advertise your product or service here.

The Rvers- Now Streaming

RVTravel.com Logo

  • Create New...